AssuredPartners Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AssuredPartners Investment Advisors's ELV Position: Q2 2026 in Review
AssuredPartners Investment Advisors increased its Elevance Health (ELV) stake by 8.9% in Q2 2026, buying an estimated $24.5K and bringing the position to 808 shares worth $312K. The position accounts for 0.03% of the portfolio, ranked #334.
AssuredPartners Investment Advisors first reported a position in ELV in Q4 2024 and has held it in 5 quarters since. The position peaked at $483K in Q1 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- AssuredPartners Investment Advisors held 808 shares of Elevance Health worth $312K as of Q2 2026.
- AssuredPartners Investment Advisors bought 66 Elevance Health shares in Q2 2026, an estimated $24.5K.
- Elevance Health made up 0.03% of AssuredPartners Investment Advisors's portfolio in Q2 2026, its #334 holding.
- AssuredPartners Investment Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 5 quarters since.
- AssuredPartners Investment Advisors's Elevance Health position peaked at $483K in Q1 2025.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on AssuredPartners Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.